Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7423 USD | -0.44% | +0.31% | -18.65% |
Financials (USD)
Sales 2024 * | 80M | Sales 2025 * | - | Capitalization | 168M |
---|---|---|---|---|---|
Net income 2024 * | -172M | Net income 2025 * | -194M | EV / Sales 2024 * | 2.94 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.08
x | P/E ratio 2025 * |
-0.99
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | -0.44% | ||
1 week | +0.31% | ||
Current month | +4.55% | ||
1 month | -25.75% | ||
3 months | -14.68% | ||
6 months | +41.71% | ||
Current year | -18.65% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.7423 | -0.44% | 1,049,955 |
24-05-09 | 0.7456 | -1.30% | 1,682,721 |
24-05-08 | 0.7554 | +3.27% | 4,245,939 |
24-05-07 | 0.7315 | -6.30% | 2,115,496 |
24-05-06 | 0.7807 | +5.50% | 8,510,626 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.65% | 168M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- GOSS Stock